Back to all papers

Beyond FDG: a paradigm shift in precision localization of epileptogenic zones in refractory epilepsy using multimodal molecular imaging (PET/CT) and isotropic 3D MRI fusion.

July 24, 2026pubmed logopapers

Authors

Zhao Y,Shen B,Luo W,Wang M

Affiliations (2)

  • Department of Radiology, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, No. 1558 North Third Ring Road, Huzhou, 313000, Zhejiang, China. [email protected].
  • Department of Radiology, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, No. 1558 North Third Ring Road, Huzhou, 313000, Zhejiang, China.

Abstract

Surgical resection for drug-resistant focal epilepsy relies on the precise presurgical localization of the epileptogenic zone (EZ). Although [<sup>1</sup>⁸F]FDG-PET has historically served as a diagnostic cornerstone, its clinical utility is often constrained by anatomy-metabolism decoupling. This non-specific glucose hypometabolism frequently extends beyond the true EZ due to the bystander effect, complicating surgical margin delineation in MRI-negative patients and those with focal cortical dysplasia (FCD). While [<sup>1</sup>⁸F]FDG-PET and ictal SPECT remain the guideline-endorsed cornerstones of routine clinical care, this review explores the emerging investigational transition toward advanced multimodal molecular-structural fusion strategies. We evaluate novel PET radiotracers designed to target proximal pathophysiological mechanisms of epileptogenesis, including synaptic density degradation (SV2A), microglial-mediated neuroinflammation (TSPO), neurotransmitter system imbalances (GABA_A, mGluR5), and dysregulated amino acid metabolism (AMT). Furthermore, we outline the integration of these mechanism-based molecular probes with high-resolution isotropic 3D MRI frameworks and artificial intelligence-driven coregistration pipelines. Clinical evidence across various epilepsy subtypes demonstrates that this multimodal approach enhances the detection of subtle histopathological lesions, refines surgical boundaries, and optimizes invasive stereoelectroencephalography (SEEG) trajectories. Ultimately, transitioning to molecular-structural coupling provides a robust framework to advance precision epilepsy surgery and improve postoperative outcomes.

Topics

Drug Resistant EpilepsyMagnetic Resonance ImagingMultimodal ImagingPositron Emission Tomography Computed TomographyImaging, Three-DimensionalMolecular ImagingJournal ArticleReview

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.